Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
about
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysisReconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxiaComparative and functional genomics of Rhodococcus opacus PD630 for biofuels developmentInvestigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targetsSoftware applications for flux balance analysisSystems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensisMetaMerge: scaling up genome-scale metabolic reconstructions, with application to Mycobacterium tuberculosisMetabolome based reaction graphs of M. tuberculosis and M. leprae: a comparative network analysisInterpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid productionCharacterization of the metabolic requirements in yeast meiosisCONSTRICTOR: constraint modification provides insight into design of biochemical networksFlux Balance Analysis with Objective Function Defined by Proteomics Data-Metabolism of Mycobacterium tuberculosis Exposed to MefloquineUnderstanding communication signals during mycobacterial latency through predicted genome-wide protein interactions and boolean modelingIdentification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tubercularsThe spectrum of latent tuberculosis: rethinking the biology and intervention strategiesTuberQ: a Mycobacterium tuberculosis protein druggability databasePredicting biological system objectives de novo from internal state measurements.Improved Metabolic Models for E. coli and Mycoplasma genitalium from GlobalFit, an Algorithm That Simultaneously Matches Growth and Non-Growth Data Sets.Pathway switching explains the sharp response characteristic of hypoxia response network.Global self-organization of the cellular metabolic structure.Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.Metabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii.Microarray data can predict diurnal changes of starch content in the picoalga OstreococcusComparative genomics of cell envelope components in mycobacteria.Two-stage flux balance analysis of metabolic networks for drug target identification.Identifying co-targets to fight drug resistance based on a random walk model.Tuberculosis: global approaches to a global disease.Quantitative analysis of cellular metabolic dissipative, self-organized structuresNetwork-based assessment of the selectivity of metabolic drug targets in Plasmodium falciparum with respect to human liver metabolismBacterial growth and cell division: a mycobacterial perspective.Interplay between constraints, objectives, and optimality for genome-scale stoichiometric models.New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.Stoichiometric Representation of Gene-Protein-Reaction Associations Leverages Constraint-Based Analysis from Reaction to Gene-Level Phenotype PredictionPhysiology of mycobacteriaA Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis.Systems biology approaches to understanding mycobacterial survival mechanisms.Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.Challenges, successes and hopes in the development of novel TB therapeutics.Metabolic network modeling and simulation for drug targeting and discovery.Computational systems approach for drug target discovery.
P2860
Q21202793-641B130A-715C-465A-A1E3-A1C3B6D3D568Q21245221-7F780745-9075-42D7-80BF-E2A0C6798EFAQ21563379-58F58DA4-E64E-4F2D-B789-76D3A7AD4672Q24669561-8208A596-68CF-4D2A-876B-E15499918278Q26824185-5281AC35-4A89-4C8C-82B9-0BE9B3DBE098Q27499012-7103FA52-7A9A-48A5-8922-893CC35BF1B8Q27499682-00A4F035-A835-4A3E-83F0-BDCB18E8E6DDQ28469296-BD2E3DED-C36E-4BAF-9D86-8E76BF84F02CQ28475985-D61190A2-868A-4358-A84F-B5A5C8006E29Q28487914-B149667A-3020-499D-8877-C047DCB8F340Q28545184-864C2E10-FEAD-451A-A212-6110F7485738Q28546822-AF04BB06-461B-45C3-BBAF-DEB8A8E8AD68Q28731026-540B9053-CC46-4C37-B201-D2E8D1A17FEAQ28833704-9A590F37-0DF3-496E-84C2-217A709793E6Q29619404-7CB0A25C-E44A-4A20-BB02-E9FA3F28C2E8Q30362399-619E15B1-6DC8-46B4-A91F-E4DB3A3E0209Q30443523-A59C5EC3-ED41-417B-88C2-8C16D63965D9Q31119097-CC4D36AC-2178-499E-9F41-20DA08B167B2Q33296881-C063A780-E6D4-4F88-82AB-371689B6FD00Q33366523-90804B1E-AC10-4232-8B60-75C9E2D4D5D3Q33395486-FC280808-5689-4C74-9176-7522474D5DF8Q33689651-54C157F6-7EC1-498B-8631-3FC070647BEAQ33830181-F5D9A927-9F32-497E-BF42-62C79F1B531EQ33900542-BB044D16-0535-4C25-8F62-1989AEE9F3C5Q33937472-C71158FA-A483-46DD-9B4A-AD5F32D15272Q34132379-F40EBE4C-EBC3-4552-BC40-F8A18CAACD07Q34143218-146FBF5F-E366-4411-8564-A3FC1DB7FD4DQ34205663-6FEA421A-D288-480D-9C17-7FC7859D1FBFQ34399911-8C9DB64E-5650-40DB-B3BC-F71D341BB4EEQ34655886-7A5FCE4E-F2FA-4F86-B1A0-4586BFD8D4D2Q35596545-B0E0CFB4-6127-4852-9737-9DB4785BA30DQ36057012-9328B2DF-9013-487E-A675-51FBE590D0D8Q36154863-BD3A61D7-01D4-4030-8E11-892EA2AB491DQ37058451-76394C63-AF75-4511-8928-D7830984CFC2Q37129868-B365B3E4-A82D-41D2-8973-3856CE3DD887Q37808939-6D2F0D91-044B-4BDE-86A7-82D270BF9909Q37825826-A678F046-CED4-4FB2-9704-CA0B30EA8098Q37855851-9A199144-C7DC-4D83-9983-130FA8357335Q37962486-C09CF18A-F29C-4EE8-8C40-D76D8FD207A6Q38088344-D6582545-1F0D-4527-B444-28F6093386A9
P2860
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@ast
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en-gb
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@nl
type
label
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@ast
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en-gb
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@nl
altLabel
Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs
@en
prefLabel
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@ast
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en-gb
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@nl
P2860
P3181
P1476
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs
@en
P2093
Nagasuma Chandra
Preethi Rajagopalan
P2860
P3181
P356
10.1371/JOURNAL.PCBI.0010046
P407
P577
2005-10-01T00:00:00Z